A Missouri engineering professor has developed a process to use off-the-shelf 3D printers to make devices that can test medicines and treatments on tissues and cells.
Appointment supports acceleration of revenue opportunities from SiNERGY™ silicon nitride devices and antipathogenic fibrous material technologies ...
BOSTON, MA, UNITED STATES, February 2, 2026 /EINPresswire.com/ -- TheraDep Technologies Inc today announced an ...
Brown, co-founder and CEO of Ponda, explains how climate innovation sits at the intersection of science, policy, and ...
Drug conjugates (ADCs) developed at Institute of Science Tokyo combine a CD4 mimic with neutralizing antibodies for enhanced suppression of human immunodeficiency virus (HIV) infection. By targeting ...
1dOpinion
Nobel chemistry laureate Frances Arnold: ‘Whole swaths of science are just going to die on the vine’
The Caltech professor on using AI to harness the power of enzymes — and what US funding cuts could mean for research ...
Living cells are highly organized, yet they are not assembled using rigid blueprints or by following a predetermined plan.
Scientists at McGill University and the Rosalind and Morris Goodman Cancer Institute have developed a new way to deliver cancer immunotherapy that caused fewer side effects compared to standard ...
New sites expected to further accelerate patient enrollment, which surpassed 50% in Phase III study, as well as support ...
Cellulose, the main strengthening component of wood, is the most abundant polymer on Earth, and is the basis of papermaking.
The Spinal Implants Market has emerged as a vital segment within the global medical device industry, driven by the increasing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results